Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.64 |
| ▸ | CTSK | P43235 | 2/20 | 0.63 |
| ▸ | CTSB | P07858 | 1/20 | 0.63 |
| ▸ | CTSS | P25774 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 3/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.62 |
| ▸ | GFER | P55789 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.60 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | PRCP | P42785 | 1/20 | 0.58 |
| ▸ | PREP | P48147 | 1/20 | 0.58 |
| ▸ | KDM1A | O60341 | 1/20 | 0.58 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26477642 | 0.96 | NPSR1 (0.68) | NPSR1CTSKTSHRL3MBTL1KDM4E | |
| SCHEMBL8428146 | 0.96 | NPSR1 (0.68) | NPSR1CTSKTSHRL3MBTL1KDM4E | |
| SCHEMBL8426716 | 0.96 | NPSR1 (0.68) | NPSR1CTSKTSHRL3MBTL1KDM4E | |
| SCHEMBL630096 | 0.86 | FKBP1A (0.71) | NPSR1CTSKCTSBCTSSTSHR | |
| SCHEMBL3578099 | 0.86 | FKBP1A (0.71) | NPSR1CTSKCTSBCTSSTSHR | |
| SCHEMBL5717010 | 0.86 | CTSK (0.61) | NPSR1CTSKCTSBCTSSTSHR | |
| SCHEMBL13119286 | 0.86 | PREP (0.61) | NPSR1CTSKCTSBCTSSTSHR | |
| SCHEMBL14828710 | 0.86 | PREP (0.61) | NPSR1CTSKCTSBCTSSTSHR | |
| SCHEMBL13500680 | 0.86 | PREP (0.61) | NPSR1CTSKCTSBCTSSTSHR | |
| SCHEMBL82714 | 0.86 | PREP (0.62) | NPSR1CTSKCTSBCTSSTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120165309-A1 | HETERO RING DERIVATIVE | ASTELLAS PHARMA INC. (JP) | 2012-06-28 | — | — | US | disclosed |
| EP-2397479-A1 | HETERO RING DERIVATIVE | Astellas Pharma Inc. (JP) | 2011-12-21 | — | — | EP | disclosed |
| WO-2010092962-A1 | HETERO RING DERIVATIVE | アステラス製薬株式会社 (JP) | 2010-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120165309-A1 | HETERO RING DERIVATIVE | IL2, PIK3R2, IL2RA | NPSR1 3370/4885CTSK 3074/4885CTSB 2480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.